2/3
08:44 am
rare
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
Low
Report
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $60.00 price target on the stock.
1/5
08:02 am
rare
Rating for RARE
Low
Report
Rating for RARE
1/5
08:02 am
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
12:55 pm
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
12:53 pm
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
12:53 pm
rare
Rating for RARE
Low
Report
Rating for RARE
12/30
07:50 am
rare
Rating for RARE
High
Report
Rating for RARE
12/30
07:50 am
rare
Rating for RARE
High
Report
Rating for RARE
12/30
07:41 am
rare
Rating for RARE
High
Report
Rating for RARE
12/30
07:41 am
rare
Rating for RARE
High
Report
Rating for RARE
11/24
09:40 am
rare
Rating for RARE
Low
Report
Rating for RARE
11/24
09:40 am
rare
Rating for RARE
Low
Report
Rating for RARE